Seminars in Nuclear Medicine
Volume 39, Issue 1 , Pages 36-51 , January 2009

Positron Emission Tomography as a Diagnostic Tool in Infection: Present Role and Future Possibilities

  • Sandip Basu, MBBS (Hons), DRM, DNB, MNAMS

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
    • Radiation Medicine Center (BARC), Tata Memorial Center Annexe, Parel, Mumbai, India
    • ,
  • Timothy Chryssikos, BA

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
    • ,
  • Siamak Moghadam-Kia, MD

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
    • ,
  • Hongming Zhuang, MD, PhD

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
    • Department of Radiology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA
    • ,
  • Drew A. Torigian, MD, MA

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
    • ,
  • Abass Alavi, MD, PhD (Hon), DSc (Hon)

      Affiliations

    • Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, PA
    • Corresponding Author InformationAddress reprint requests to Abass Alavi, MD, PhD (Hon), DSc (Hon), Division of Nuclear Medicine, Hospital of the University of Pennsylvania, 110 Donner Building, 3400 Spruce Street, Philadelphia, PA 19104

References 

  1. Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am. 2005;43:121–134
  2. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59
  3. Koljevic-Markovic A, Orcurto MV, Doenz F. Persistent FDG uptake around an inguinal mesh prosthesis 25 years after implantation. Clin Nucl Med. 2007;32:242–243
  4. Julian A, Payoux P, Rimailho J, et al. Uterine uptake of F-18 FDG on positron emission tomography induced by an intrauterine device: Unusual pitfall. Clin Nucl Med. 2007;32:128–129
  5. Kawai S, Ikeda E, Sugiyama M. Enhancement of splenic glucose metabolism during acute malarial infection: Correlation of findings of FDG-PET imaging with pathological changes in a primate model of severe human malaria. Am J Trop Med Hyg. 2006;74:353–360
  6. Cheng CY, Huang WS, Shen DH. FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis. Clin Nucl Med. 2007;32:117–1121
  7. Shie P, Farukhi I, Hughes RS, et al. Round pneumonia mimicking pulmonary malignancy on F-18 FDG PET/CT. Clin Nucl Med. 2007;32:55–56
  8. McDivitt JD, Arluk GM, Turton DB. Incidental detection of Helicobacter pylori gastritis during FDG PET scanning for lymphoma. Clin Nucl Med. 2008;33:113–114
  9. Zhang Y, Xiu Y, Zhuang H. Follow-up FDG PET in the evaluation of unexplained focal activity in the abdomen. Clin Nucl Med. 2008;33:19–22
  10. Yu JQ, Kung JW, Potenta S, et al. Chronic cholecystitis detected by FDG-PET. Clin Nucl Med. 2004;29:496–497
  11. Yu JQ, Kumar R, Xiu Y, et al. Diffuse FDG uptake in the lungs in aspiration pneumonia on positron emission tomographic imaging. Clin Nucl Med. 2004;29:567–568
  12. Lustberg MB, Aras O, Meisenberg BR. FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma. Eur J Haematol. 2008;81:154–156
  13. Alavi A, Zhuang H. Finding infection—help from PET. Lancet. 2001;358:1386
  14. Fu Y, Maianu L, Melbert BR, et al. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: Arole for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis. 2004;32:182–190
  15. Zhao S, Kuge Y, Tsukamoto E, et al. Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: Effects of insulin and glucose loading. Nucl Med Commun. 2002;23:545–550
  16. Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: Can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?. Nucl Med Commun. 2007;28:465–472
  17. Keidar Z, Militianu D, Melamed E, et al. The diabetic foot: Initial experience with 18F-FDG PET/CT. J Nucl Med. 2005;46:444–449
  18. Hochhold J, Yang H, Zhuang H, et al. Application of 18F-fluorodeoxyglucose and PET in evaluation of the diabetic foot PET. Clin North Am. 2006;1:123–130
  19. Chryssikos T, Parvizi J, Ghanem E. FDG-PET imaging can diagnose periprosthetic infection of the hip. Clin Orthop Relat Res. 2008;466:1338–1342
  20. Zhuang H, Yang H, Alavi A. Critical role of 18F-labeled fluorodeoxyglucose PET in the management of patients with arthroplasty. Radiol Clin North Am. 2007;45:711–718vii
  21. Sterner T, Pink R, Freudenberg L, et al. The role of [18F]fluoride positron emission tomography in the early detection of aseptic loosening of total knee arthroplasty. Int J Surg. 2007;5:99–104
  22. Pill SG, Parvizi J, Tang PH, et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty. 2006;21:91–97(suppl 2)
  23. Kumar R, Basu S, Torigian D. Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev. 2008;21:209–224
  24. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35–45
  25. Depas G, Decortis T, Francotte N, et al. F-18 FDG PET in infectious diseases in children. Clin Nucl Med. 2007;32:593–598
  26. El-Haddad G, Abass A, Zhuang H. Value of 18-fluoro-2-deoxyglucose PET in the management of patients with fever of unknown origin. PET Clin North Am. 2006;1:163–177
  27. Venneti S, Bonneh-Barkay D, Lopresti BJ. Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synaptic degeneration. Am J Pathol. 2008;172:1603–1616
  28. Brust D, Polis M, Davey R, et al. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: Impact of disease stage and therapy on pattern of nodal activation. Aids. 2006;20:985–993
  29. Lauwers P, Van den Broeck S, Carp L, et al. The use of positron emission tomography with (18)F-fluorodeoxyglucose for the diagnosis of vascular graft infection. Angiology. 2007;58:717–724
  30. Keidar Z, Engel A, Hoffman A, et al. Prosthetic vascular graft infection: The role of 18F-FDG PET/CT. J Nucl Med. 2007;48:1230–1236
  31. Strobel K, Zippelius A, Hany TF. FDG PET/CT imaging of a gastric fistula. Clin Nucl Med. 2007;32:336–337
  32. Win Z, O'Rourke E, Todd J, et al. Vesico-colic fistula as demonstrated by [18F]FDG-PET. Eur J Nucl Med Mol Imaging. 2006;33:107
  33. Choi SJ, Lee JS, Cheong MH, et al. F-18 FDG PET/CT in the management of infected abdominal aortic aneurysm due to salmonella. Clin Nucl Med. 2008;33:492–495
  34. Yu J, Zhuang H, Mavi A, et al. Evaluating the role of fluorodeoxyglucose PET imaging in the management of patients with sarcoidosis. PET Clin North Am. 2006;1:141–152
  35. Huang SS, Yu J, Chamroonrat W, et al. Achilles tendonitis detected by FDG-PET. Clin Nucl Med. 2006;31:147–148
  36. Houseni M, Chamroonrat W, Zhuang H, et al. Facet joint arthropathy demonstrated on FDG-PET. Clin Nucl Med. 2006;31:418–419
  37. Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol. 2008;63:756–764
  38. Basu S, Alavi A. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: Should these be routinely employed in assessing patients with cancer?. Eur J Nucl Med Mol Imaging. 2007;34:1527–1529
  39. Xiu Y, Bhutani C, Dhurairaj T, et al. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32:101–105
  40. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412–1417
  41. Lehmann K, Behe M, Meller J, et al. F-18-FDG uptake in granulocytes: Basis of F-18-FDG scintigraphy for imaging infection. J Nucl Med. 2001;42:1384;(abstr)
  42. Ishimori T, Saga T, Mamede M, et al. Increased (18)F-FDG uptake in a model of inflammation: Concanavalin A-mediated lymphocyte activation. J Nucl Med. 2002;43:658–663
  43. Mamede M, Saga T, Ishimori T, et al. Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification. Neoplasia. 2003;5:179–183
  44. Ahmed N, Berridge MV. Distinct regulation of glucose transport by interleukin-3 and oncogenes in a murine bone marrow-derived cell line. Biochem Pharmacol. 1999;57:387–396
  45. Ahmed N, Kansara M, Berridge MV. Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochem J. 1997;327:369–375
  46. Gamelli RL, Liu H, He LK, et al. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol. 1996;59:639–647
  47. Gamelli RL, Liu H, He LK, et al. Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice. Shock. 1994;1:395–400
  48. Chakrabarti R, Jung CY, Lee TP, et al. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol. 1994;152:2660–2668
  49. Heelan BT, Osman S, Blyth A, et al. Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography. Transplantation. 1998;66:1101–1103
  50. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–1980
  51. Sorbara LR, Maldarelli F, Chamoun G, et al. Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression. J Virol. 1996;70:7275–7279
  52. Hartmann A, Eid K, Dora C, et al. Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2007;34:704–714
  53. Prandini N, Lazzeri E, Rossi B, et al. Nuclear medicine imaging of bone infections. Nucl Med Commun. 2006;27:633–644
  54. Robiller FC, Stumpe KD, Kossmann T, et al. Chronic osteomyelitis of the femur: Value of PET imaging. Eur Radiol. 2000;10:855–858
  55. Zhuang H, Duarte PS, Pourdehand M, et al. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med. 2000;25:281–284
  56. Guhlmann A, Brecht-Krauss D, Suger G, et al. Chronic osteomyelitis: Detection with FDG PET and correlation with histopathologic findings. Radiology. 1998;206:749–754
  57. Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med. 1998;39:2145–2152
  58. de Winter F, van de Wiele C, Vogelaers D, et al. Fluorine-18 fluorodeoxyglucose-position emission tomography: A highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am. 2001;83-A:651–660
  59. Chacko TK, Zhuang H, Nakhoda KZ, et al. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun. 2003;24:615–624
  60. Pineda C, Vargas A, Rodriguez AV. Imaging of osteomyelitis: current concepts. Infect Dis Clin North Am. 2006;20:789–825
  61. Palestro CJ, Kim CK, Swyer AJ, et al. Radionuclide diagnosis of vertebral osteomyelitis: Indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J Nucl Med. 1991;32:1861–1865
  62. Termaat MF, Raijmakers PG, Scholten HJ, et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: A systematic review and meta-analysis. J Bone Joint Surg Am. 2005;87:2464–2471
  63. el Esper I, Dacquet V, Paillard J, et al. 99Tcm-HMPAO-labelled leucocyte scintigraphy in suspected chronic osteomyelitis related to an orthopaedic device: Clinical usefulness. Nucl Med Commun. 1992;13:799–805
  64. Meller J, Koster G, Liersch T, et al. Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111)In-labelled autologous leucocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2002;29:53–60
  65. Love C, Palestro CJ. 18F-FDG and 67Ga-SPECT imaging in suspected vertebral osteomyelitis: An intraindividual comparison. J Nucl Med. 2003;45:148P;(suppl) (abstr)
  66. Gratz S, Dorner J, Fischer U, et al. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging. 2002;29:516–524
  67. Stumpe KD, Zanetti M, Weishaupt D, et al. FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR Am J Roentgenol. 2002;179:1151–1157
  68. Zhuang H, Sam JW, Chacko TK, et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging. 2003;30:1096–1103
  69. Meyer M, Gast T, Raja S, et al. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med. 1994;19:13–14
  70. Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: Comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004;25:890–895
  71. Hopfner S, Krolak C, Kessler S, et al. [Preoperative imaging of Charcot neuroarthropathy: Does the additional application of (18)F-FDG-PET make sense?]. Nuklearmedizin. 2006;45:15–20
  72. Alnafisi N, Yun M, Alavi A. F-18 FDG positron emission tomography to differentiate diabetic osteoarthropathy from septic arthritis. Clin Nucl Med. 2001;26:638–639
  73. Nawaz A, Torigian D, Zhuang H, et al. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) in the diagnosis of acute osteomyelitis in the diabetic foot. J Nucl Med. 2008;49:134P;(suppl 1)
  74. Zhuang HM, Cortes-Blanco A, Pourdehnad M, et al. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders?. Nucl Med Commun. 2001;22:1123–1128
  75. Zhuang H, Chacko TK, Hickeson M, et al. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur J Nucl Med Mol Imaging. 2002;29:1328–1333
  76. Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med. 2001;42:44–48
  77. Vanquickenborne B, Maes A, Nuyts J, et al. The value of (18)FDG-PET for the detection of infected hip prosthesis. Eur J Nucl Med Mol Imaging. 2003;30:705–715
  78. Love C, Pugliese PV, Afriyie MO, et al. Utility of F-18 FDG imaging for diagnosing the infected joint replacement. Clin Positron Imaging. 2000;3:159
  79. Love C, Marwin SE, Tomas MB, et al. Diagnosing infection in the failed joint replacement: A comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med. 2004;45:1864–1871
  80. Stumpe KD, Notzli HP, Zanetti M, et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: Comparison with conventional radiography and three-phase bone scintigraphy. Radiology. 2004;231:333–341
  81. Chacko TK, Zhuang H, Stevenson K, et al. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun. 2002;23:851–855
  82. Zoccali C, Teori G, Salducca N: The role of FDG-PET in distinguishing between septic and aseptic loosening in hip prosthesis: A review of literature. Int Orthop 2008 Jul 2 [Epub ahead of print]
  83. Petersdorf RG. FUO: How it has changed in 20 years. Hosp Pract (Off Ed). 1985;20:84I–84M84P, 84T–84V passim
  84. Petersdorf RG. Fever of unknown origin (An old friend revisited). Arch Intern Med. 1992;152:21–22
  85. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191–196
  86. Stumpe KD, Dazzi H, Schaffner A, et al. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27:822–832
  87. Gungor T, Engel-Bicik I, Eich G, et al. Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child. 2001;85:341–345
  88. Meller J, Altenvoerde G, Munzel U, et al. Fever of unknown origin: Prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPECT. Eur J Nucl Med. 2000;27:1617–1625
  89. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29–37
  90. Yen RF, Chen YC, Wu YW, et al. Using 18-fluoro-2-deoxyglucose positron emission tomography in detecting infectious endocarditis/endoarteritis: A preliminary report. Acad Radiol. 2004;11:316–321
  91. Federici L, Blondet C, Imperiale A, et al: Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: A single centre analysis experience. Int J Clin Pract 2008 May 7 [Epub ahead of print]
  92. Hoffman JM, Waskin HA, Schifter T, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med. 1993;34:567–575
  93. O'Doherty MJ, Barrington SF, Campbell M, et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med. 1997;38:1575–1583
  94. Heald AE, Hoffman JM, Bartlett JA, et al. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS. 1996;7:337–346
  95. Scharko AM, Perlman SB, Pyzalski RW, et al. Whole-body positron emission tomography in patients with HIV-1 infection. Lancet. 2003;362:959–961
  96. Scharko AM, Perlman SB, Hinds PW, et al. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci USA. 1996;93:6425–6430
  97. Santiago JF, Jana S, Gilbert HM, et al. Role of fluorine-18-fluorodeoxyglucose in the work-up of febrile AIDS patients experience with dual head coincidence imaging. Clin Positron Imaging. 1999;2:301–309
  98. Krupnick AS, Lombardi JV, Engels FH, et al. 18-fluorodeoxyglucose positron emission tomography as a novel imaging tool for the diagnosis of aortoenteric fistula and aortic graft infection—a case report. Vasc Endovascular Surg. 2003;37:363–366
  99. Rohde H, Horstkotte MA, Loeper S, et al. Recurrent Listeria monocytogenes aortic graft infection: Confirmation of relapse by molecular subtyping. Diagn Microbiol Infect Dis. 2004;48:63–67
  100. Fukuchi K, Ishida Y, Higashi M, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: Comparison with computed tomographic findings. J Vasc Surg. 2005;42:919–925
  101. Tegler G, Sorensen J, Bjorck M, et al. Detection of aortic graft infection by 18-fluorodeoxyglucose positron emission tomography combined with computed tomography. J Vasc Surg. 2007;45:828–830
  102. Wasikova S, Staffa R, Kriz Z, et al. [Treatment of vascular prosthesis infection and aorto-enteric fistula as a late complication after reconstructive surgery of the abdominal aorta–a case report]. Rozhl Chir. 2007;86:522–524
  103. Balink H, Reijnen MM. Diagnosis of abdominal aortic prosthesis infection with FDG-PET/CT. Vasc Endovascular Surg. 2007;41:428–432
  104. van Assen S, Houwerzijl EJ, van den Dungen JJ, et al. Vascular graft infection due to chronic Q fever diagnosed with fusion positron emission tomography/computed tomography. J Vasc Surg. 2007;46:372
  105. Tsunekawa T, Ogino H, Minatoya K, et al. Masked prosthetic graft to sigmoid colon fistula diagnosed by 18-fluorodeoxyglucose positron emission tomography. Eur J Vasc Endovasc Surg. 2007;33:187–189
  106. Carlos MG, Juliana R, Matilde N, et al. Hidden clotted vascular access infection diagnosed by fluorodeoxyglucose positron emission tomography. Nephrology (Carlton). 2008;13:264–265
  107. Gugatschka M, Schwarz T, Friedrich G: Positron emission tomography/computed tomography as a method for detection and monitoring of laryngeal chondritis. Eur Arch Otorhinolaryngol 2008 Mar 26 [Epub ahead of print]
  108. Cobbaert K, Pieters A, Devinck M, et al. Brucellar spondylodiscitis: Case report. Acta Clin Belg. 2007;62:304–307
  109. Helleman JN, Hendriks JM, Deblier I, et al. Mycotic aneurysm of the descending thoracic aorta. Review and case report. Acta Chir Belg. 2007;107:544–547
  110. Takano H, Nakagawa K, Ishio N, et al: Active myocarditis in a patient with chronic active Epstein-Barr virus infection. Int J Cardiol 2007 Oct 1 [Epub ahead of print]
  111. Maldonado F, Daniels CE, Hoffman EA, et al. Focal organizing pneumonia on surgical lung biopsy: Causes, clinicoradiologic features, and outcomes. Chest. 2007;132:1579–1583
  112. Sheehy N, Israel DA. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT. Clin Nucl Med. 2007;32:820–821
  113. Wyss MT, Honer M, Spath N, et al. Influence of ceftriaxone treatment on FDG uptake—an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats. Nucl Med Biol. 2004;31:875–882
  114. Hakim SG, Bruecker CW, Jacobsen H, et al. The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible. Int J Oral Maxillofac Surg. 2006;35:809–816
  115. Win Z, O'Flynn E, O'Rourke EJ, et al. F-18 FDG PET in the diagnosis and monitoring of salmonella vertebral osteomyelitis: A comparison with MRI. Clin Nucl Med. 2006;31:437–440
  116. Ozsahin H, von Planta M, Muller I, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood. 1998;92:2719–2724
  117. Bleeker-Rovers CP, de Sevaux RG, van Hamersvelt HW, et al. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2003;41:E18–E21
  118. Bleeker-Rovers CP, Warris A, Drenth JP, et al. Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Infect. 2005;11:493–495
  119. Win Z, Todd J, Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med. 2005;30:690–691
  120. Reuter S, Buck A, Manfras B, et al. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology. 2004;39:509–517
  121. Ehrhardt AR, Reuter S, Buck AK, et al: Assessment of disease activity in alveolar echinococcosis: A comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography. Abdom Imaging 2007 Feb 7 [Epub ahead of print]
  122. Stumpe KD, Renner-Schneiter EC, Kuenzle AK, et al. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: Prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection. 2007;35:11–18
  123. Chamilos G, Macapinlac HA, Kontoyiannis DP. The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol. 2008;46:23–29
  124. Li YJ, Cai L, Sun HR, et al. Increased FDG uptake in bilateral adrenal tuberculosis appearing like malignancy. Clin Nucl Med. 2008;33:191–192
  125. Lin KH, Wang JH, Peng NJ. Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan. Clin Nucl Med. 2008;33:276–277
  126. Takalkar AM, Bruno GL, Reddy M, et al. Intense FDG activity in peritoneal tuberculosis mimics peritoneal carcinomatosis. Clin Nucl Med. 2007;32:244–246
  127. Li YJ, Zhang Y, Gao S, et al. Systemic disseminated tuberculosis mimicking malignancy on F-18 FDG PET-CT. Clin Nucl Med. 2008;33:49–51
  128. Park IN, Ryu JS, Shim TS. Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin Nucl Med. 2008;33:1–3

PII: S0001-2998(08)00101-3

doi: 10.1053/j.semnuclmed.2008.08.004

Seminars in Nuclear Medicine
Volume 39, Issue 1 , Pages 36-51 , January 2009

Article Tools

* Image Usage & Resolution